José-Carlos Benítez-Montañez

6PUBLICATIONS
79CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2025
Paving the way for ctDNA-guided trials in lung cancer: insights from the LIBELULE study.

Jose Carlos Benitez, Antonio Rueda-Domínguez

|Dec 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Sep 12, 2024
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative review.

Mora Guardamagna, May-Lucie Meyer, Miguel Ángel Berciano-Guerrero

|Apr 27, 2024
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.

Juan Zafra, Juan Luis Onieva, Javier Oliver

|Jul 14, 2023
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade.

Javier Oliver, Juan Luis Onieva, María Garrido-Barros

Pageof 1

Frequent Collaborators

3 joint publications

Elisabeth Pérez-Ruiz

2 joint publications

Javier Oliver

2 joint publications

Juan Luis Onieva

2 joint publications

Juan Zafra Martín